A1 and A2b adenosine receptors regulate GPX4 against ferroptosis of cardiomyocytes in myocardial infarction rat model and in vitro
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Developmental Biology,General Medicine
Reference49 articles.
1. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes;Baba;Am. J. Physiol. Heart Circ. Physiol.,2018
2. Quantification of adenosine a(1) receptor biased agonism: implications for drug discovery;Baltos;Biochem. Pharmacol.,2016
3. Adenosine A1 agonist at reperfusion trial (Aart): results of a three-center, blinded, randomized, controlled experimental infarct study;Baxter;Cardiovasc. Drugs Ther.,2000
4. Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused st-segment-elevation myocardial infarction and adverse left ventricular remodeling;Bulluck;Circ. Cardiovasc. Imaging,2016
5. Adenosine A2a and A2b receptor substantially attenuate ischemia/reperfusion injury in septic rat hearts;Busse;Cardiovasc Drugs Ther.,2016
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Interplay between Mechanoregulation and ROS in Heart Physiology, Disease, and Regeneration;Advanced Healthcare Materials;2024-07-04
2. Gastrodin prevents myocardial injury in sleep-deprived mice by suppressing ferroptosis through SIRT6;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-19
3. Notoginsenoside R1 (NGR1) regulates the AGE-RAGE signaling pathway by inhibiting RUNX2 expression to accelerate ferroptosis in breast cancer cells;Aging;2024-06-14
4. The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia–reperfusion injury;Life Sciences;2024-03
5. Ferroptosis, a Regulated Form of Cell Death, as a Target for the Development of Novel Drugs Preventing Ischemia/Reperfusion of Cardiac Injury, Cardiomyopathy and Stress-Induced Cardiac Injury;International Journal of Molecular Sciences;2024-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3